Mesoblast Limited (ASX:MSB)
Australia
· Delayed Price · Currency is AUD 2.660
+0.120 (4.72%)
At close: Dec 5, 2025
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
323.85K AUD
Profits / Employee
-1.92M AUD
Market Cap
3.41B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CSL Limited | 29,904 |
| Pro Medicus | 132 |
| Cochlear | 5,500 |
| Sonic Healthcare | 45,000 |
| Ramsay Health Care | 90,000 |
| Ansell | 15,000 |
| Telix Pharmaceuticals | 234 |
| Neuren Pharmaceuticals | 8 |
Mesoblast News
- 2 days ago - Mesoblast Participation at Piper Sandler Conference - GlobeNewsWire
- 10 days ago - This Brinker International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 11 days ago - Analyst Upgrade for Mesoblast (MESO): Jefferies Lifts Rating to Buy | MESO Stock News - GuruFocus
- 11 days ago - Mesoblast Sees Continued Ryoncil Revenue Growth For Q4 2025 - Nasdaq
- 11 days ago - Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil® Revenue - GlobeNewsWire
- 15 days ago - MESO: Mesoblast Announces Pivotal Trial Collaboration for Ryoncil in Severe aGvHD - GuruFocus
- 15 days ago - Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids - GlobeNewsWire
- 19 days ago - Mesoblast Appoints James M O'Brien New CFO - Nasdaq